MapLight Therapeutics, Inc. - MPLT
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Aug 20, 2026 | SCHEDULE 13G | Nan Fung Group Holdings Limited | 5.5% | 2,915,874 | View |
| Aug 20, 2026 | SCHEDULE 13G | NF Investment Holdings Limited | 5.5% | 2,911,774 | View |
| Aug 20, 2026 | SCHEDULE 13G | Nan Fung Life Sciences Holdings Limited | 2.4% | 1,283,052 | View |
| Aug 20, 2026 | SCHEDULE 13G | NFLS Platform Holdings Limited | 1.3% | 671,606 | View |
| Aug 20, 2026 | SCHEDULE 13G | Pivotal Life Sciences Holdings Limited | 1.2% | 611,446 | View |
| Aug 20, 2026 | SCHEDULE 13G | Pivotal Partners Ltd | 1.2% | 611,446 | View |
| Aug 20, 2026 | SCHEDULE 13G | Pivotal bioVenture Partners Fund II G.P. Ltd | 1.2% | 611,446 | View |
| Aug 20, 2026 | SCHEDULE 13G | Pivotal bioVenture Partners Fund II, L.P. | 1.2% | 611,446 | View |
| Aug 20, 2026 | SCHEDULE 13G | NFLS Beta Limited | 1.3% | 671,606 | View |
| Aug 20, 2026 | SCHEDULE 13G | Permwell Management Limited | 3.1% | 1,628,722 | View |
| Aug 18, 2026 | SCHEDULE 13D/A | — | 49.99% | — | View |
| Aug 03, 2026 | SCHEDULE 13D/A | — | — | — | View |
| Jul 31, 2026 | SCHEDULE 13D/A | — | 4.9% | — | View |
| May 15, 2026 | SCHEDULE 13G/A | T. Rowe Price Investment Management, Inc. | 7.4% | 3,137,558 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.